Dr. Fred F. Soeprono, MD

Dr. Soeprono practices at Soeprono Medical Corporation in Loma Linda, California.

Dr. Soeprono's NPI, 1659485746, was assigned on August 18, 2006. Dr. Soeprono graduated from Loma Linda University School Of Medicine in 1973. Dr. Soeprono's California license number on file is G28216.

Dr. Soeprono's primary practice is Soeprono Medical Corporation, at 25084 Barton Rd, Loma Linda, CA 92354 in San Bernardino County. The practice phone is (909) 792-8600.

Dr. Soeprono's primary practice is Soeprono Medical Corporation in Loma Linda, California. The medical group on file is High Desert Skin & Laser Medical Center. Dmand AI also links Dr. Soeprono to 2 more group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Soeprono practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Soeprono's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Soeprono is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Soeprono's licenses on file in 3 states: California, New York and Washington.

Dmand AI lists acute skin infection, benign or precancerous skin growths, contact dermatitis, itchy rashes, minor injury to a limb, scalp rash, skin discoloration and yeast infection among the conditions Dr. Soeprono treats.

CMS data shows 3,319 Medicare services from Dr. Soeprono across 9 procedure codes in 2024, for 734 Medicare patients. Medicare paid $212,290 for them. Every service was in an office.

CMS counts 734 Medicare patients who saw Dr. Soeprono in 2024. The largest group is 65 to 74, with 304 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Soeprono's median patient age at 72, with 55% women.

In 2024, Dr. Soeprono wrote 30 Medicare Part D claims for 15 patients. 90% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $11 in total drug cost. In 2018, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 77 out of 100 for Dr. Soeprono for performance year 2024, reported as part of a group. Dr. Soeprono accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of skin cancer: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Soeprono, published from 2007 to 2019. The most frequent topics are Diagnosis, Differential and Skin. Dr. Soeprono's most frequent co-authors are Nancy J. Anderson, MD, Victoria Regina Barrio, MD and Yuchi C. Chang, MD.

Dmand AI links Dr. Soeprono to 1 clinical trial. Conditions studied include Eczema and Dermatitis, Atopic. Open Payments lists research payments to Dr. Soeprono that name 1 trial.

CMS Open Payments shows 16 general payments to Dr. Soeprono from 7 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 68% of the total. Pfizer Inc. paid the most, $669. It also lists 7 research payments totaling $1,220 in 2017, naming 1 clinical trial.

Dmand AI lists 3 awards for Dr. Soeprono, most recently CMS Stage 1 EHR in 2013.

Dr. Soeprono graduated from Loma Linda University School Of Medicine in 1973. Dr. Soeprono is a member of AAD and ASDS.

Dr. Soeprono is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.